HomeInsights
INDUSTRY:
Pharma
TOPIC:
Products & Services, Business & People, Manufacturers & Providers
TITLE:
European Commission (EC) Question & Answer document for patients builds trust and understanding on biosimilar medicines across Europe
BRIEF:
According to Medicines for Europe, the document is written by and for patients in need of information on the use of biosimilar medicines as an alternative therapeutic option.
LEGAL IMPLICATIONS:
BUSINESS IMPLICATIONS:
